RICTOR and non-small cell lung carcinoma: Furthermore, a preliminary report using an in vivo mouse model of NSCLC showed that RICTOR knockdown inhibits lung cancer tumor growth and spread in the brain, suggesting that RICTOR may represent an important therapeutic target for treating or preventing brain metastases [107].